RETROSPECTIVE STUDY TO KNOW THE EFFICACY OF ACTAEA RACEMOSA IN CENTESIMAL POTENCY IN THE PAIN MANAGEMENT OF CERVICAL SPONDYLOSIS

Abstract

Background:
Cervical spondylosis is a common degenerative disorder of the cervical spine, often associated with chronic pain, stiffness, and neurological symptoms, significantly impairing quality of life. While conventional treatments provide symptomatic relief, they may have limitations in long-term efficacy and safety. This study explores the therapeutic potential of Actaea racemosa in centesimal potency for managing Cervical spondylosis-related pain by using the visual analogue scale (VAS).

Objective:
To evaluate the efficacy of Actaea racemosa 200C in reducing pain and improving associated symptoms in patients with cervical spondylosis.

Methods:
A retrospective observational study was conducted on 30 patients diagnosed with cervical spondylosis at the outpatient department of JIMS homoeopathic medical college over a period of four months. Data were collected from case records, and changes in pain (assessed via the Visual Analogue Scale), mobility, and associated symptoms such as vertigo, radiation, and tingling were documented before and after treatment with Actaea racemosa 30C and 200C.

Results:
Post-treatment, 83.33% of patients showed pain reduction to a VAS score of 1–5, compared to 10% pre-treatment. Mobility improved in 96.66% of cases. Neurological symptoms such as radiation of pain (70% pre-treatment) and tingling (36.66%) were notably reduced. The greatest improvement was observed in patients under 30 and in females, with a consistent trend of better outcomes in early intervention.

Conclusion:
Actaea racemosa 200C demonstrated marked effectiveness in the management of cervical spondylosis, particularly in reducing pain and improving functional mobility. These findings support its role as a valuable homoeopathic intervention for CS, warranting further validation through controlled clinical trials.